Consortium Acquisition of Ambrx, Inc.

Represented a consortium of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund and WuXi PharmaTech in the acquisition of Ambrx, Inc.

Participating Lawyers

Sort By

Email Disclaimer